NHS Logo

Carbamazepine : (Record no. 91487)

MARC details
000 -LEADER
fixed length control field 03008cam a2200541 i 4500
001 - CONTROL NUMBER
control field ocn868975208
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240729131412.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |||||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 130816t20132013nyua ob 001 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2019722594
040 ## - CATALOGING SOURCE
Original cataloging agency DLC
015 ## - NATIONAL BIBLIOGRAPHY NUMBER
National bibliography number GBB3B8580
Source bnb
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 016589591
Source Uk
019 ## -
-- 867904138
-- 923672992
-- 928194929
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781629480633
Qualifying information ebook
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1629480630
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9781629480480
Qualifying information pbk.
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 1629480487
Qualifying information pbk.
035 ## - SYSTEM CONTROL NUMBER
System control number 662151
-- (N$T)
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)868975208
Canceled/invalid control number (OCoLC)867904138
-- (OCoLC)923672992
-- (OCoLC)928194929
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 071000
Source bisacsh
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Carbamazepine :
Subtitle medical uses, pharmacokinetics and adverse effects
Statement of responsibility, etc
Medium [E-Book]
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture New York :
Name of producer, publisher, distributor, manufacturer Nova Biomedical,
Date of production, publication, distribution, manufacture, or copyright notice [2013]
300 ## - PHYSICAL DESCRIPTION
Physical description 1 online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES TITLE
Series statement Pharmacology - research, safety testing and regulation
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - CONTENTS
Contents Ch. I Carbamazepine Pharmacokinetic and Drug Interactions in Poly-Treated Patients / Swati Jaiswal -- ch. II Effect of Carbamazepine and Related Compounds on Ligand-Gated Ion Channels: Possible Implications for Synaptic Transmission and Side Effects / Andrea Becchetti -- ch. III Carbamazepine and its Derivatives: What's the Difference? / Emilio Russo -- ch. IV Clinical Use of Carbamazepine in Neurological Non-Epileptic Diseases / Antonio Siniscalchi -- ch. V Environmental Fate and Remediation of Carbamazepine in the Hydrosphere / J. Arturo Santaballa.
520 ## - ABSTRACT
Abstract Carbamazepine (CBZ), one of the most used antiepileptic drugs (AEDs), was introduced on the market in the early 1960's and ever since, it has become the most frequently prescribed drug for the treatment of several forms of epilepsy. It is also used to treat other pathologies, such as neuropathic pain and psychiatric disorders. This book provides a detailed description of this drug, evaluating all aspects of its pharmacology. CBZ pharmacokinetics is discussed, with a particular emphasis on its metabolism, side effects and drug interactions. Then the authors focus on its pharmacodynamic effects,
590 ## - LOCAL NOTE (RLIN)
Local note Master record variable field(s) change: 050, 082
650 #0 - SUBJECT HEADINGS
Subject term Carbamazepine.
9 (RLIN) 5505
650 #0 - SUBJECT HEADINGS
Subject term Anticonvulsants.
9 (RLIN) 5238
700 1# - ADDED PERSONAL NAME
Added personal author Gallelli, Luca,
Relator term editor of compilation.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Pharmacology - research, safety testing and regulation.
856 ## - ONLINE RESOURCE
Uniform Resource Identifier <a href="#gotoholdings">#gotoholdings</a>
Link text Access resource
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Suppress in OPAC Do not Suppress in OPAC
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on print version record.
938 ## -
-- YBP Library Services
-- YANK
-- 11319952
938 ## -
-- EBSCOhost
-- EBSC
-- 662151
938 ## -
-- ebrary
-- EBRY
-- ebr10792499
938 ## -
-- ProQuest Ebook Central
-- EBLB
-- EBL2145951
994 ## -
-- 92
-- N$T
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Total Checkouts Date last seen Uniform Resource Identifier Price effective from Koha item type
        Stenhouse Library (Kingston Hospital) Stenhouse Library (Kingston Hospital) Online 28/11/2022 eBook EBSCO clinical collection   28/11/2022 https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=662151 28/11/2022 Electronic book
London Health Libraries Consortium Privacy notice and Membership terms and conditions